Komlossy Law, P.A. Announces Investigation of Conceptus, Inc.

  Komlossy Law, P.A. Announces Investigation of Conceptus, Inc.

Business Wire

HOLLYWOOD, Fla. -- April 30, 2013

Komlossy Law, P.A. is investigating the Board of Directors of Conceptus, Inc.
(“Conceptus” or the “Company”) (Nasdaq:CPTS) for possible breaches of
fiduciary duty and other violations of state law in connection with their
attempt to complete a sale of the Company to Bayer HealthCare LLC in a
transaction valued at approximately $1.1 billion. Pursuant to the terms of the
proposed transaction, Conceptus shareholders are to receive $31.00 in cash for
each share.

The investigation involves whether the Board of Directors of Conceptus
breached their fiduciary duties to stockholders by favoring the interests of
certain officers and directors of the Company in the proposed acquisition, and
whether the transaction is fair to shareholders with respect to price, process
and disclosure of all material information.

If you own Conceptus stock and wish to obtain additional information about
your rights as a shareholder, or if you have information about the above
investigation, please contact Emily C. Komlossy, Esq. via email at
eck@komlossylaw.com or Ross A. Appel, Esq. at raa@komlossylaw.com or by
telephone toll free at (855) 858-1233.

Komlossy Law, P.A. represents shareholders in complex litigation, including
class action and derivative litigation. Komlossy Law, P.A. may co-counsel with
another firm, or refer a case to another firm. More information is available
through its website, www.komlossylaw.com/CPTS, and upon request from the firm.
Emily C. Komlossy is the attorney responsible for the content of this release.

Attorney Advertisement. Past results do not guarantee or predict a similar
outcome with respect to any future matter.


Komlossy Law, P.A.
Emily C. Komlossy, Esq., 855-858-1233
Press spacebar to pause and continue. Press esc to stop.